- Home
- CCM vs TPST Comparison
CCM vs TPST Comparison
Compare CCM & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- TPST
- Stock Information
- Founded
- CCM 1997
- TPST 2011
- Country
- CCM China
- TPST United States
- Employees
- CCM N/A
- TPST N/A
- Industry
- CCM Medical/Nursing Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- TPST Health Care
- Exchange
- CCM Nasdaq
- TPST Nasdaq
- Market Cap
- CCM 25.1M
- TPST 27.2M
- IPO Year
- CCM 2009
- TPST N/A
- Fundamental
- Price
- CCM $5.08
- TPST $0.97
- Analyst Decision
- CCM
- TPST Strong Buy
- Analyst Count
- CCM 0
- TPST 4
- Target Price
- CCM N/A
- TPST $20.00
- AVG Volume (30 Days)
- CCM 6.1K
- TPST 3.3M
- Earning Date
- CCM 11-22-2024
- TPST 11-12-2024
- Dividend Yield
- CCM N/A
- TPST N/A
- EPS Growth
- CCM N/A
- TPST N/A
- EPS
- CCM N/A
- TPST N/A
- Revenue
- CCM $64,910,622.00
- TPST N/A
- Revenue This Year
- CCM N/A
- TPST N/A
- Revenue Next Year
- CCM N/A
- TPST N/A
- P/E Ratio
- CCM N/A
- TPST N/A
- Revenue Growth
- CCM N/A
- TPST N/A
- 52 Week Low
- CCM $3.80
- TPST $0.86
- 52 Week High
- CCM $26.70
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- CCM 33.74
- TPST 42.46
- Support Level
- CCM $4.47
- TPST $0.94
- Resistance Level
- CCM $9.07
- TPST $1.16
- Average True Range (ATR)
- CCM 0.72
- TPST 0.09
- MACD
- CCM -0.32
- TPST 0.01
- Stochastic Oscillator
- CCM 21.37
- TPST 39.34
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.